Concurrent versus sequential immunotherapy with chemoradiotherapy for unresectable stage III non-small-cell lung cancer: a retrospective study

Concurrent versus sequential immunotherapy with chemoradiotherapy for unresectable stage III non-small-cell lung cancer: a retrospective study

BackgroundImmunotherapy combined with chemoradiotherapy has demonstrated promising efficacy in stage III non-small-cell lung cancer (NSCLC). However, the optimal timing for immunotherapy intervention during radiotherapy remains unclear. This study aimed to compare the efficacy and safety of immune c...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhou Meng-Xi, Fan Wen-Jie, Zhang Ning, Zhu Li-Yang, Wang Hong-Yan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
immunotherapy
sequential immunotherapy
chemoradiotherapy
NSCLC
efficacy
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1515382/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items